DB 290
Latest Information Update: 08 Sep 2000
At a glance
- Originator Nonindustrial source
- Developer Immtech Pharmaceuticals; Nonindustrial source
- Class Antifungals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pneumocystis pneumonia
Most Recent Events
- 08 Sep 2000 Discontinued-Preclinical for Pneumocystis pneumonia in USA (PO)
- 27 Nov 1997 Preclinical development for Pneumocystis pneumonia in USA (PO)